Patient sex and its influence on general anaesthesia

Anaesthesia and Intensive Care

Volumn 37, Issue 2, 2009, Pages 207-218

  Buchanan, F F ^a   Myles, P S ^a,b   Cicuttini, F ^a,b  

^a ALFRED HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Anaesthesia; Analgesia; Gender; Outcome

Indexed keywords

ALFENTANIL; ALPRAZOLAM; ATRACURIUM; CHLORPROMAZINE; DESFLURANE; DESIPRAMINE; DIAZEPAM; ELTANOLONE; ENFLURANE; ERYTHROMYCIN; HALOTHANE; ISOFLURANE; LIDOCAINE; MIDAZOLAM; MUSCLE RELAXANT AGENT; OXAZEPAM; PANCURONIUM; PARACETAMOL; PETHIDINE; PHENYTOIN; PROPOFOL; PROPRANOLOL; ROCURONIUM; SALICYLIC ACID; SEX HORMONE; TEMAZEPAM; THEOPHYLLINE; VECURONIUM; VERAPAMIL; XENON; ANESTHETIC AGENT; CYP3A4 PROTEIN, HUMAN; CYTOCHROME P450 3A; FOLLITROPIN;

ANESTHETIC RECOVERY; ARTICLE; BODY COMPOSITION; BRAIN FUNCTION; CARDIOVASCULAR PARAMETERS; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG METABOLISM; GENERAL ANESTHESIA; GLOMERULUS FILTRATION RATE; GLUCOSE METABOLISM; HUMAN; KIDNEY BLOOD FLOW; KIDNEY CLEARANCE; MENSTRUAL CYCLE; METABOLIC RATE; PHARMACODYNAMICS; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE PAIN; PREMENOPAUSE; PROTEIN BINDING; RESPIRATORY TRACT PARAMETERS; SEX DIFFERENCE; BLOOD; BODY TEMPERATURE; BRAIN; BREATHING; FEMALE; MALE; METABOLISM; PHYSIOLOGY; REVIEW; SEXUAL DEVELOPMENT;

ANESTHESIA, GENERAL; ANESTHETICS; BODY COMPOSITION; BODY TEMPERATURE; BRAIN; CYTOCHROME P-450 CYP3A; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; MALE; PROTEIN BINDING; RESPIRATION; SEX CHARACTERISTICS;

EID: 65549090533     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x0903700201     Document Type: Article

References (164)

1. Holdcroft A. Females and their variability. Anaesthesia 1997; 52:931-934.
2. Ciccone GK, Holdcroft A. Drugs and sex differences: a review of drugs relating to anaesthesia. Br J Anaesth 1999; 82:255-265. (Pubitemid 29057626)
3. Kashuba AD, Nafziger AN. Physiological changes during the menstrual cycle and their effects on the pharmacokinetics and pharmacodynamics of drugs. Clin Pharmacokinet 1998; 34:203-218. (Pubitemid 28112399)
4. Kando JC, Yonkers KA, Cole JO. Gender as a risk factor for adverse events to medications. Drugs 1995; 50:1-6.
5. Gan TJ, Glass PS, Sigl J, Sebel P, Payne F, Rosow C et al. Women emerge from general anesthesia with propofol/alfentanil/ nitrous oxide faster than men. Anesthesiology 1999; 90:1283-1287. (Pubitemid 29205630)
6. Myles PS, McLeod AD, Hunt JO, Fletcher H. Sex differences in speed of emergence and quality of recovery after anaesthesia: cohort study. BMJ 2001; 322:710-711. (Pubitemid 32238777)
7. Apfelbaum JL, Grasela TH, Hug CC Jr, McLeskey CH, Nahrwold ML, Roizen MF et al. The initial clinical experience of 1819 physicians in maintaining anesthesia with propofol: characteristics associated with prolonged time to awakening. Anesth Analg 1993; 77:S10-14.
8. Hoymork SC, Raeder J, Grimsmo B, Steen PA. Bispectral index, serum drug concentrations and emergence associated with individually adjusted target-controlled infusions of remifentanil and propofol for laparoscopic surgery. Br J Anaesth 2003; 91:773-780. (Pubitemid 37508815)
9. Buchanan FF, Myles PS, Leslie K, Forbes A, Cicuttini F. Gender and recovery after general anesthesia combined with neuromuscular blocking drugs. Anesth Analg 2006; 102:291-297. (Pubitemid 43038324)
10. Pleym H, Spigset O, Kharasch ED, Dale O. Gender differences in drug effects: implications for anesthesiologists. Acta Anaesthesiol Scand 2003; 47:241-259. (Pubitemid 36384661)
11. Moller DH, Glass PSA. Should a patient's gender alter the anaesthetic plan? Curr Opin Anaesthesiol 2003; 16:379-383.
12. Shaw RW. Neuroendocrinology of the menstrual cycle in humans. Clin Endocrinol Metab 1978; 7:531-559. (Pubitemid 9064260)
13. Paeratakul S, Adair LS, Zhai F, Ge K, Popkin BM. Sex difference in measures of body fatness and the possible difference in the effect of dietary fat on body fatness in men and women. Eur J Clin Nutr 1999; 53:865-871. (Pubitemid 29532994)
14. Buchholz AC, Rafii M, Pencharz PB. Is resting metabolic rate different between men and women? Br J Nutr 2001; 86:641-646.
15. Stachenfeld NS, Taylor HS. Effects of estrogen and progesterone administration on extracellular fluid. J Appl Physiol 2004; 96:1011-1018. (Pubitemid 38248677)
16. Stachenfeld NS, Silva C, Keefe DL, Kokoszka CA, Nadel ER. Effects of oral contraceptives on body fluid regulation. J Appl Physiol 1999; 87:1016-1025. (Pubitemid 29436979)
17. Olson BR, Forman MR, Lanza E, McAdam PA, Beecher G, Kimzey LM et al. Relation between sodium balance and menstrual cycle symptoms in normal women. Ann Intern Med 1996; 125:564-567. (Pubitemid 126450089)
18. Landau RL, Lugibihi K, Bergenstal DM, Dimick DF. The metabolic effects of progesterone in man: dose response relationships. J Lab Clin Med 1957; 50:613-620.
19. Lauer MS, Anderson KM, Larson MG, Levy D. A new method for indexing left ventricular mass for differences in body size. Am J Cardiol 1994; 74:487-491. (Pubitemid 24269970)
20. de Simone G, Devereux RB, Maggioni AP, Gorini M, de Divitiis O, Verdecchia P et al. Different normalizations for body size and population attributable risk of left ventricular hypertrophy: the MAVI study. Am J Hypertens 2005; 18:1288-1293. (Pubitemid 41400196)
21. Cain PA, Ahl R, Hedstrom E, Ugander M, Allansdotter- Johnsson A, Friberg P et al. Physiological determinants of the variation in left ventricular mass from early adolescence to late adulthood in healthy subjects. Clin Physiol Funct Imaging 2005; 25:332-339. (Pubitemid 41700632)
22. Grandi AM, Venco A, Barzizza F, Scalise F, Pantaleo P, Finardi G. Influence of age and sex on left ventricular anatomy and function in normals. Cardiology 1992; 81:8-13.
23. Chung AK, Das SR, Leonard D, Peshock RM, Kazi F, Abdullah SM et al. Women have higher left ventricular ejection fractions than men independent of differences in left ventricular volume: the Dallas Heart Study. Circulation 2006; 113:1597-1604. (Pubitemid 43739419)
24. Legato MJ. Gender and the heart: sex-specific differences in normal anatomy and physiology. J Gend Specif Med 2000; 3:15-18.
25. Burke JH, Goldberger JJ, Ehlert FA, Kruse JT, Parker MA, Kadish AH. Gender differences in heart rate before and after autonomic blockade: evidence against an intrinsic gender effect. Am J Med 1996; 100:537-543. (Pubitemid 26170478)
26. Wiinberg N, Høegholm A, Christensen HR, Bang LE, Mikkelsen KL, Nielsen PE et al. 24-h ambulatory blood pressure in 352 normal Danish subjects, related to age and gender. Am J Hypertens 1995; 8:978-986.
27. Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension 1995; 26:60-69.
28. Reckelhoff JF. Gender differences in the regulation of blood pressure. Hypertension 2001; 37:1199-1208. (Pubitemid 34163570)
29. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999; 340:1801-1811. (Pubitemid 29266405)
30. Dubey RK, Oparil S, Imthurn B, Jackson EK. Sex hormones and hypertension. Cardiovasc Res 2002; 53:688-708. (Pubitemid 34175262)
31. Mead J. Dysanapsis in normal lungs assessed by the relationship between maximal flow, static recoil, and vital capacity. Am Rev Respir Dis 1980; 121:339-342. (Pubitemid 10095228)
32. McClaran SR, Harms CA, Pegelow DF, Dempsey JA. Smaller lungs in women affect exercise hyperpnea. J Appl Physiol 1998; 84:1872-1881. (Pubitemid 28255946)
33. Harms CA, McClaran SR, Nickele GA, Pegelow DF, Nelson WB, Dempsey JA. Exercise-induced arterial hypoxaemia in healthy young women. J Physiol 1998; 507:619-628. (Pubitemid 28135209)
34. Kilbride E, McLoughlin P, Gallagher CG, Harty HR. Do gender differences exist in the ventilatory response to progressive exercise in males and females of average fitness? Eur J Appl Physiol 2003; 89:595-602.
35. Mead J. Dysanapsis in normal lungs assessed by the relationship between maximal flow, static recoil, and vital capacity. Am Rev Respir Dis 1980; 121:339-342. (Pubitemid 10095228)
36. Thurlbeck WM. Postnatal human lung growth. Thorax 1982; 37:564-571. (Pubitemid 12036031)
37. Charkoudian N, Joyner MJ. Physiologic considerations for exercise performance in women. Clin Chest Med 2004; 25:247-255. (Pubitemid 38507645)
38. Morelli C, Badr MS, Mateika JH. Ventilatory responses to carbon dioxide at low and high levels of oxygen are elevated after episodic hypoxia in men compared with women. J Appl Physiol 2004; 97:1673-1680. (Pubitemid 39425982)
39. Regensteiner JG, Pickett CK, McCullough RE, Weil JV, Moore LG. Possible gender differences in the effect of exercise on hypoxic ventilatory response. Respiration 1988; 53:158-165. (Pubitemid 18153992)
40. Jensen D, Wolfe LA, O'Donnell DE, Davies GAL. Chemoreflex control of breathing during wakefulness in healthy men and women. J Appl Physiol 2005; 98:822-828. (Pubitemid 40283660)
41. Bayliss DA, Millhorn DE. Central neural mechanisms of progesterone action: application to the respiratory system. J Appl Physiol 1992; 73:393-404.
42. Schoene RB, Robertson HT, Pierson DJ, Peterson AP. Respiratory drives and exercise in menstrual cycles of athletic and nonathletic women. J Appl Physiol 1981; 50:1300-1305. (Pubitemid 11078949)
43. Preston RJ, Heenan AP, Wolfe LA. Physicochemical analysis of phasic menstrual cycle effects on acid-base balance. Am J Physiol Regul Integr Comp Physiol 2001; 280:R481-487.
44. Miller JA, Anacta LA, Cattran DC. Impact of gender on the renal response to angiotensin II. Kidney Int 1999; 55:278-285. (Pubitemid 29004260)
45. Wesson LG. Renal hemodynamics in physiological states. In: The Physiology of the Human Kidney, New York, Grune and Stratton 1969. p. 96-106.
46. Harris RZ, Benet LZ, Schwartz JB. Gender effects in pharmacokinetics and pharmacodynamics. Drugs 1995; 50:222-239.
47. Slack TK, Wilson DM. Normal renal function: CIN and CPAH in healthy donors before and after nephrectomy. Mayo Clin Proc 1976; 51:296-300.
48. Pechere-Bertschi A, Burnier M. Female sex hormones, salt, and blood pressure regulation. Am J Hypertens 2004; 17:994-1001. (Pubitemid 39361675)
49. Danser AH, Derkx FH, Schalekamp MA, Hense HW, Riegger GA, Schunkert H. Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans. J Hypertens 1998; 16:853-862. (Pubitemid 28247969)
50. Ferraro R, Lillioja S, Fontvieille AM, Rising R, Bogardus C, Ravussin E. Lower sedentary metabolic rate in women compared with men. J Clin Invest 1992; 90:780-784.
51. Buchholz AC, Rafii M, Pencharz PB. Is resting metabolic rate different between men and women? Br J Nutr 2001; 86:641-646.
52. Webb P. 24-hour energy expenditure and the menstrual cycle. Am J Clin Nutr 1986; 44:614-619. (Pubitemid 17194664)
53. Kaciuba-Uscilko H, Grucza R. Gender differences in thermoregulation. Curr Opin Clin Nutr Metab Care 2001; 4:533-536. (Pubitemid 34755412)
54. Goldstein JM, Seidman LJ, Horton NJ, Makris N, Kennedy DN, Caviness VS Jr et al. Normal sexual dimorphism of the adult human brain assessed by in vivo magnetic resonance imaging. Cereb Cortex 2001; 11:490-497. (Pubitemid 32488376)
55. Rabinowicz T, Dean DE, Petetot JM, de Courten-Myers GM. Gender differences in the human cerebral cortex: more neurons in males; more processes in females. J Child Neurol 1999; 14:98-107. (Pubitemid 29146620)
56. Kawachi T, Ishii K, Sakamoto S, Matsui M, Mori T, Sasaki M. Gender differences in cerebral glucose metabolism: a PET study. J Neurol Sci 2002; 199:79-83. (Pubitemid 34663839)
57. Cahill L, Uncapher M, Kilpatrick L, Alkire MT, Turner J. Sex-related hemispheric lateralization of amygdala function in emotionally influenced memory: an FMRI investigation. Learn Mem 2004; 11:261-266. (Pubitemid 38697891)
58. Gandhi M, Aweeka F, Greenblatt RM, Blaschke TF. Sex differences in pharmacokinetics and pharmacodynamics. Annu Rev Pharmacol Toxicol 2004; 44:499-523. (Pubitemid 38263851)
59. Hutson WR, Roehrkasse RL, Wald A. Influence of gender and menopause on gastric emptying and motility. Gastroenterology 1989; 96:11-17. (Pubitemid 19046261)
60. Datz FL, Christian PE, Moore J. Gender-related differences in gastric emptying. J Nucl Med 1987; 28:1204-1207. (Pubitemid 17146840)
61. Singer AJ, Brandt LJ. Pathophysiology of the gastrointestinal tract during pregnancy. Am J Gastroenterol 1991; 86:1695-1712.
62. Gill RC, Murphy PD, Hooper HR, Bowes KL, Kingma YJ. Effect of the menstrual cycle on gastric emptying. Digestion 1987; 36:168-174. (Pubitemid 17053805)
63. Horowitz M, Maddern GJ, Chatterton BE, Collins PJ, Petrucco OM, Seamark R et al. The normal menstrual cycle has no effect on gastric emptying. Br J Obstet Gynaecol 1985; 92:743-746. (Pubitemid 15048757)
64. Chen M-L. Confounding factors for sex differences in pharmacokinetics and pharmacodynamics: focus on dosing regimen, dosage form, and formulation. Clin Pharmacol Ther 2005; 78:322-329. (Pubitemid 41393667)
65. Frezza M, di Padova C, Pozzato G, Terpin M, Baraona E, Lieber CS. High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and firstpass metabolism. N Engl J Med 1990; 322:95-99. (Pubitemid 20023867)
66. Jones BM, Jones MK. Alcohol effects in women during the menstrual cycle. Ann N Y Acad Sci 1976; 273:576-587.
67. Lammers SM, Mainzer DE, Breteler MH. Do alcohol pharmacokinetics in women vary due to the menstrual cycle? Addiction 1995; 90:23-30.
68. Xue FS, Liao X, Liu JH, Tong SY, Zhang YM, Zhang RJ, An G et al. Dose-response curve and time-course of effect of vecuronium in male and female patients. Br J Anaesth 1998; 80:720-724. (Pubitemid 28282540)
69. Xue FS, An G, Liao X, Zou Q, Luo LK. The pharmacokinetics of vecuronium in male and female patients. Anesth Analg 1998; 86:1322-1327.
70. Semple P, Hope DA, Clyburn P, Rodbert A. Relative potency of vecuronium in male and female patients in Britain and Australia. Br J Anaesth 1994; 72:190-194. (Pubitemid 24054339)
71. Houghton IT, Aun CS, Oh TE. Vecuronium: an anthropometric comparison. Anaesthesia 1992; 47:741-746.
72. Xue FS, Tong SY, Liao X, Liu JH, An G, Luo LK. Doseresponse and time course of effect of rocuronium in male and female anesthetized patients. Anesth Analg 1997; 85:667-671.
73. Donati F, Bevan D. The influence of patient's sex, age and weight on pancuronium onset time. Can J Anaesth 1986; 33:586.
74. Parker CJ, Hunter JM, Snowdon SL. Effect of age, sex and anaesthetic technique on the pharmacokinetics of atracurium. Br J Anaesth 1992; 69:439-443.
75. Greenblatt DJ, Allen MD, Harmatz JS, Shader RI. Diazepam disposition determinants. Clin Pharmacol Ther 1980; 27:301-312. (Pubitemid 10063481)
76. Ochs HR, Greenblatt DJ, Divoll M, Abernethy DR, Feyerabend H, Dengler HJ. Diazepam kinetics in relation to age and sex. Pharmacology 1982; 23:24-30.
77. Greenblatt DJ, Abernethy DR, Locniskar A, Harmatz JS, Limjuco RA, Shader RI. Effect of age, gender, and obesity on midazolam kinetics. Anesthesiology 1984; 61:27-35. (Pubitemid 14089351)
78. Vuyk J, Oostwouder CJ, Vletter AA, Burm AG, Bovill JG. Gender differences in the pharmacokinetics of propofol in elderly patients during and after continuous infusion. Br J Anaesth 2001; 86:183-188. (Pubitemid 32103405)
79. Shafer A, Doze VA, Shafer SL, White PF. Pharmacokinetics and pharmacodynamics of propofol infusions during general anesthesia. Anesthesiology 1988; 69:348-356. (Pubitemid 18226631)
80. Dale O, Hynne H, Parivar K, Johansson E, Widman M. Pharmacokinetics of eltanolone in male and female patients following intravenous bolus injection. Acta Anaesthesiol Scand 1999; 43:415-420. (Pubitemid 29186109)
81. Verbeeck RK, Cardinal JA, Wallace SM. Effect of age and sex on the plasma binding of acidic and basic drugs. Eur J Clin Pharmacol 1984; 27:91-97. (Pubitemid 14033886)
82. Tsen LC, Arthur GR, Datta S, Hornstein MD, Bader AM. Estrogen-induced changes in protein binding of bupivacaine during in vitro fertilization. Anesthesiology 1997; 87:879-883. (Pubitemid 27456242)
83. Walle UK, Fagan TC, Topmiller MJ, Conradi EC, Walle T. The influence of gender and sex steroid hormones on the plasma binding of propranolol enantiomers. Br J Clin Pharmacol 1994; 37:21-25. (Pubitemid 24204576)
84. Wood M, Wood AJ. Changes in plasma drug binding and alpha 1-acid glycoprotein in mother and newborn infant. Clin Pharmacol Ther 1981; 29:522-526. (Pubitemid 11039807)
85. Schmidt R, Baumann F, Hanschmann H, Geissler F, Preiss R. Gender difference in ifosfamide metabolism by human liver microsomes. Eur J Drug Metab Pharmacokinet 2001; 26:193-200. (Pubitemid 32988561)
86. Hunt CM, Westerkam WR, Stave GM. Effect of age and gender on the activity of human hepatic CYP3A. Biochem Pharmacol 1992; 44:275-283.
87. Schmucker DL, Woodhouse KW, Wang RK, Wynne H, James OF, McManus M et al. Effects of age and gender on in vitro properties of human liver microsomal monooxygenases. Clin Pharmacol Ther 1990; 48:365-374. (Pubitemid 20362269)
88. Chiou WL, Jeong HY, Wu TC, Ma C. Use of the erythromycin breath test for in vivo assessments of cytochrome P4503A activity and dosage individualization. Clin Pharmacol Ther 2001; 70:305-310. (Pubitemid 33022470)
89. Watkins PB, Turgeon DK, Saenger P, Lown KS, Kolars JC, Hamilton T et al. Comparison of urinary 6-beta-cortisol and the erythromycin breath test as measures of hepatic P450IIIA (CYP3A) activity. Clin Pharmacol Ther 1992; 52:265-273.
90. Krecic-Shepard ME, Barnas CR, Slimko J, Jones MP, Schwartz JB. Gender-specific effects on verapamil pharmacokinetics and pharmacodynamics in humans. J Clin Pharmacol 2000;40:219-230.
91. Thummel KE, Shen DD, Podoll TD, Kunze KL, Trager WF, Bacchi CE et al. Use of midazolam as a human cytochrome P450 3A probe: II. Characterization of inter- and intraindividual hepatic CYP3A variability after liver transplantation. J Pharmacol Exp Ther 1994; 271:557-566. (Pubitemid 24333174)
92. Thummel KE, Shen DD, Podoll TD, Kunze KL, Trager WF, Bacchi CE et al. Use of midazolam as a human cytochrome P450 3A probe: II. Characterization of inter- and intraindividual hepatic CYP3A variability after liver transplantation. J Pharmacol Exp Ther 1994; 271:557-566. (Pubitemid 24333174)
93. Nishiyama T, Matsukawa T, Hanaoka K. The effects of age and gender on the optimal premedication dose of intramuscular midazolam. Anesth Analg 1998; 86:1103-1108. (Pubitemid 28198888)
94. Kashuba AD, Bertino JS Jr, Rocci ML Jr, Kulawy RW, Beck DJ, Nafziger AN. Quantification of 3-month intraindividual variability and the influence of sex and menstrual cycle phase on CYP3A activity as measured by phenotyping with intravenous midazolam. Clin Pharmacol Ther 1998; 64:269-277. (Pubitemid 28462287)
95. Kinirons MT, O'Shea D, Kim RB, Groopman JD, Thummel KE, Wood AJ et al. Failure of erythromycin breath test to correlate with midazolam clearance as a probe of cytochrome P4503A. Clin Pharmacol Ther 1999; 66:224-231. (Pubitemid 29451753)
96. Greenblatt DJ, Locniskar A, Scavone JM, Blyden GT, Ochs HR, Harmatz JS et al. Absence of interaction of cimetidine and ranitidine with intravenous and oral midazolam. Anesth Analg 1986; 65:176-180. (Pubitemid 16155199)
97. Gorski JC, Jones DR, Haehner-Daniels BD, Hamman MA, O'Mara EM Jr, Hall SD. The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin. Clin Pharmacol Ther 1998; 64:133-143. (Pubitemid 28423848)
98. Cummins CL, Wu C-Y, Benet LZ. Sex-related differences in the clearance of cytochrome P450 3A4 substrates may be caused by P-glycoprotein. Clin Pharmacol Ther 2002; 72:474-489. (Pubitemid 36237718)
99. Schuetz EG, Furuya KN, Schuetz JD. Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms. J Pharmacol Exp Ther 1995; 275:1011-1018. (Pubitemid 26023635)
100. Skett P. Biochemical basis of sex differences in drug metabolism. Pharmacol Ther 1988; 38:269-304.
101. Wadelius M, Darj E, Frenne G, Rane A. Induction of CYP2D6 in pregnancy. Clin Pharmacol Ther 1997; 62:400-407. (Pubitemid 27475224)
102. Oram M, Wilson K, Burnett D. The influence of oral contraceptives on the metabolism of methaqualone in man. Br J Clin Pharmacol 1982; 14:341-345. (Pubitemid 13139130)
103. Bruguerolle B, Toumi M, Faraj F, Vervloet D, Razzouk H. Influence of the menstrual cycle on theophylline pharmacokinetics in asthmatics. Eur J Clin Pharmacol 1990; 39:59-61. (Pubitemid 20216513)
104. Lane JD, Steege JF, Rupp SL, Kuhn CM. Menstrual cycle effects on caffeine elimination in the human female. Eur J Clin Pharmacol 1992; 43:543-546.
105. Kharasch ED, Mautz D, Senn T, Lentz G, Cox K. Menstrual cycle variability in midazolam pharmacokinetics. J Clin Pharmacol 1999; 39:275-280. (Pubitemid 29148550)
106. Kirkwood C, Moore A, Hayes P, DeVane C L, Pelonero A. Influence of menstrual cycle and gender on alprazolam pharmacokinetics. Clin Pharmacol Ther 1991; 50:404-409.
107. Kharasch ED, Russell M, Garton K, Lentz G, Bowdle TA, Cox K. Assessment of cytochrome P450 3A4 activity during the menstrual cycle using alfentanil as a noninvasive probe. Anesthesiology 1997; 87:26-35. (Pubitemid 27438620)
108. Rubio A, Cox C. Sex, age and alfentanil pharmacokinetics. Clin Pharmacokinet 1991; 21:81-82.
109. Lemmens HJ, Burm AG, Hennis PJ, Gladines MP, Bovill JG. Influence of age on the pharmacokinetics of alfentanil. Gender dependence. Clin Pharmacokinet 1990; 19:416-422.
110. Zeiner AR, Kegg PS. Menstrual cycle and oral contraceptive effects on alcohol pharmacokinetics in caucasian females. Curr Alcohol 1982; 8:47-56.
111. Macdonald JI, Herman RJ, Verbeeck RK. Sex-difference and the effects of smoking and oral contraceptive steroids on the kinetics of diflunisal. Eur J Clin Pharmacol 1990; 38:175-179. (Pubitemid 20097325)
112. Greenblatt DJ, Divoll M, Harmatz JS, Shader RI. Oxazepam kinetics: effects of age and sex. J Pharmacol Exp Ther 1980; 215:86-91. (Pubitemid 11072954)
113. Divoll M, Greenblatt DJ, Harmatz JS, Shader RI. Effect of age and gender on disposition of temazepam. J Pharm Sci 1981; 70:1104-1107. (Pubitemid 12198374)
114. Miners JO, Attwood J, Birkett DJ. Influence of sex and oral contraceptive steroids on paracetamol metabolism. Br J Clin Pharmacol 1983; 16:503-509. (Pubitemid 14239699)
115. Walle T, Walle UK, Cowart TD, Conradi EC. Pathwayselective sex differences in the metabolic clearance of propranolol in human subjects. Clin Pharmacol Ther 1989; 46:257-263. (Pubitemid 19254757)
116. Schnider TW, Minto CF, Gambus PL, Andresen C, Goodale DB, Shafer SL et al. The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology 1998; 88:1170-1182. (Pubitemid 28216859)
117. Cerrutti JA, Quaglia NB, Brandoni A, Torres AM. Effects of gender on the pharmacokinetics of drugs secreted by the renal organic anions transport systems in the rat. Pharmacol Res 2002; 45:107-112. (Pubitemid 35428844)
118. Gaudry SE, Sitar DS, Smyth DD, McKenzie JK, Aoki FY. Gender and age as factors in the inhibition of renal clearance of amantadine by quinine and quinidine. Clin Pharmacol Ther 1993; 54:23-27. (Pubitemid 23227512)
119. Pfaff DW, McEwen BS. Actions of estrogens and progestins on nerve cells. Science 1983; 219:808-814. (Pubitemid 13194768)
120. McEwen BS, Alves SE. Estrogen actions in the central nervous system. Endocr Rev 1999; 20:279-307. (Pubitemid 30649809)
121. Rupprecht R, Reul JM, Trapp T, van Steensel B, Wetzel C, Damm K et al. Progesterone receptor-mediated effects of neuroactive steroids. Neuron 1993; 11:523-530. (Pubitemid 23287079)
122. Majewska MD. Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance. Prog Neurobiol 1992; 38:379-395.
123. Manber R, Armitage R. Sex, steroids, and sleep: a review. Sleep 1999; 22:540-555. (Pubitemid 29379112)
124. Bitran D, Purdy RH, Kellogg CK. Anxiolytic effect of progesterone is associated with increases in cortical allopregnanolone and GABAA receptor function. Pharmacol Biochem Behav 1993; 45:423-428. (Pubitemid 23165237)
125. Nadeson R, Goodchild CS. Antinociceptive properties of neurosteroids III: experiments with alphadolone given intravenously, intraperitoneally, and intragastrically. Br J Anaesth 2001; 86:704-708. (Pubitemid 32409414)
126. Datta S, Migliozzi RP, Flanagan HL, Krieger NR. Chronically administered progesterone decreases halothane requirements in rabbits. Anesth Analg 1989; 68:46-50. (Pubitemid 19042929)
127. Merryman W, Boiman R, Barnes L, Rothchild I. Progesterone anesthesia in human subjects. J Clin Endocrinol Metab 1954; 14:1567-1569.
128. Carl P, Hogskilde S, Nielsen JW, Sorensen MB, Lindholm M, Karlen B et al. Pregnanolone emulsion. A preliminary pharmacokinetic and pharmacodynamic study of a new intravenous anaesthetic agent. Anaesthesia 1990; 45:189-197.
129. Erden V, Yangin Z, Erkalp K, Delatioglu H, Bahceci F, Seyhan A. Increased progesterone production during the luteal phase of menstruation may decrease anesthetic requirement. Anesth Analg 2005; 101:1007-1111. (Pubitemid 41383062)
130. Gee KW, Bolger MB, Brinton RE, Coirini H, McEwen BS. Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of action. J Pharmacol Exp Ther 1988; 246:803-812. (Pubitemid 18209685)
131. Harrison NL, Majewska MD, Harrington JW, Barker JL. Structure-activity relationships for steroid interaction with the gamma-aminobutyric acid A receptor complex. J Pharmacol Exp Ther 1987; 241:346-353. (Pubitemid 17119381)
132. Rudick CN, Woolley CS. Estradiol induces a phasic Fos response in the hippocampal CA1 and CA3 regions of adult female rats. Hippocampus 2000; 10:274-283. (Pubitemid 30438663)
133. Woolley CS, Schwartzkroin PA. Hormonal effects on the brain. Epilepsia 1998; 39 (Suppl 8):S2-8.
134. Foy MR, Xu J, Xie X, Brinton RD, Thompson RF, Berger TW. 17beta-estradiol enhances NMDA receptor-mediated EPSPs and long-term potentiation. J Neurophysiol 1999; 81:925-929. (Pubitemid 29264535)
135. Aloisi AM, Bonifazi M. Sex hormones, central nervous system and pain. Horm Behav 2006; 50:1-7. (Pubitemid 43792491)
136. Mashour GA. Integrating the science of consciousness and anesthesia. Anesth Analg 2006; 103:975-982. (Pubitemid 44576707)
137. Campagna JA, Miller KW, Forman SA. Mechanisms of actions of inhaled anesthetics. N Engl J Med 2003; 348:2110-2124. (Pubitemid 36583307)
138. Franks NP, Lieb WR. Molecular and cellular mechanisms of general anaesthesia. Nature 1994; 367:607-614. (Pubitemid 24067700)
139. Greif R, Laciny S, Mokhtarani M, Doufas AG, Bakhshandeh M, Dorfer L et al. Transcutaneous electrical stimulation of an auricular acupuncture point decreases anesthetic requirement. Anesthesiology 2002; 96:306-312. (Pubitemid 34121738)
140. Goto T, Nakata Y, Morita S. The minimum alveolar concentration of xenon in the elderly is sex-dependent. Anesthesiology 2002; 97:1129-1132. (Pubitemid 35265565)
141. Gin T, Chan MT. Decreased minimum alveolar concentration of isoflurane in pregnant humans. Anesthesiology 1994; 81:829-832. (Pubitemid 24332615)
142. Chan MT, Mainland P, Gin T. Minimum alveolar concentration of halothane and enflurane are decreased in early pregnancy. Anesthesiology 1996; 85:782-786. (Pubitemid 26346717)
143. Eger EI 2nd, Laster MJ, Gregory GA, Katoh T, Sonner JM. Women appear to have the same minimum alveolar concentration as men: a retrospective study. Anesthesiology 2003; 99:1059-1061.
144. Hoymork SC, Raeder J. Why do women wake up faster than men from propofol anaesthesia? Br J Anaesth 2005; 95:627-633.
145. Kodaka M, Johansen JW, Sebel PS. The influence of gender on loss of consciousness with sevoflurane or propofol. Anesth Analg 2005; 101:377-381. (Pubitemid 41045216)
146. Kreuer S, Schreiber JU, Bruhn J, Wilhelm W. Impact of patient age on propofol consumption during propofol-remifentanil anaesthesia. Eur J Anaesthesiol 2005; 22:123-128. (Pubitemid 40488645)
147. Wilhelm W, Buchinger H, Biedler A, Altmann S, Larsen R, Kreuer S. [Influence of gender on propofol consumption and recovery times]. Anaesthesist 2005; 54:567-574.
148. Leslie P, Drover DR. Women patients require more propofol for general anaesthesia than men. Anesthesiology 2001; 95:A481.
149. Glass PS, Bloom M, Kearse L, Rosow C, Sebel P, Manberg P. Bispectral analysis measures sedation and memory effects of propofol, midazolam, isoflurane, and alfentanil in healthy volunteers. Anesthesiology 1997; 86:836-847. (Pubitemid 27174724)
150. Kodaka M, Asano K, Miyao H. The propofol Cp50 of women for loss of consciousness is higher than that of men. Anesthesiology 2002; 96:A446.
151. Vuyk J, Oostwouder CJ, Vletter AA, Burm AG, Bovill JG. Gender differences in the pharmacokinetics of propofol in elderly patients during and after continuous infusion. Br J Anaesth 2001; 86:183-188. (Pubitemid 32103405)
152. Domino KB, Posner KL, Caplan RA, Cheney FW. Awareness during anesthesia: a closed claims analysis. Anesthesiology 1999; 90:1053-1061. (Pubitemid 29159763)
153. Pavlin DJ, Rapp SE, Polissar NL, Malmgren JA, Koerschgen M, Keyes H. Factors affecting discharge time in adult outpatients. Anesth Analg 1998; 87:816-826. (Pubitemid 28455476)
154. Mertes PM, Laxenaire M-C, Alla F. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology 2003; 99:536-545.
155. Taenzer AH, Clark C, Curry CS. Gender affects report of pain and function after arthroscopic anterior cruciate ligament reconstruction. Anesthesiology 2000; 93:670-675.
156. Harmon D, O'Connor P, Gleasa O, Gardiner J. Menstrual cycle irregularity and the incidence of nausea and vomiting after laparoscopy. Anaesthesia 2000; 55:1164-1167.
157. Myles PS, Hunt JO, Moloney JT. Postoperative 'minor' complications. Comparison between men and women. Anaesthesia 1997; 52:300-306.
158. Edwards FH, Carey JS, Grover FL, Bero JW, Hartz RS. Impact of gender on coronary bypass operative mortality. Ann Thorac Surg 1998; 66:125-131. (Pubitemid 28389245)
159. Butterworth J, James R, Prielipp R, Cerese J, Livingston J, Burnett D. Female gender associates with increased duration of intubation and length of stay after coronary artery surgery. CABG Clinical Benchmarking Database Participants. Anesthesiology 2000; 92:414-424.
160. Koch CG, Khandwala F, Cywinski JB, Ishwaran H, Estafanous FG, Loop FD et al. Health-related quality of life after coronary artery bypass grafting: a gender analysis using the Duke Activity Status Index. J Thorac Cardiovasc Surg 2004; 128:284-295. (Pubitemid 38969812)
161. Quintana JM, Arostegui I, Oribe V, Lopez de Tejada I, Barrios B, Garay I. Influence of age and gender on quality-of-life outcomes after cholecystectomy. Qual Life Res 2005;14:815-825. (Pubitemid 40584811)
162. Myles PS, Williams DL, Hendrata M, Anderson H, Weeks AM. Patient satisfaction after anaesthesia and surgery: results of a prospective survey of 10,811 patients. Br J Anaesth 2000; 84:6-10. (Pubitemid 30009298)
163. Beattie WS, Lindblad T, Buckley DN, Forrest JB. The incidence of postoperative nausea and vomiting in women undergoing laparoscopy is influenced by the day of menstrual cycle. Can J Anaesth 1991; 38:298-302.
164. Fujii Y, Tanaka H, Toyooka H. Granisetron reduces postoperative nausea and vomiting throughout menstrual cycle. Can J Anaesth 1997; 44:489-493. (Pubitemid 27317741)